AJICAP Second Generation: Improved Chemical Site-Specific Conjugation Technology for Antibody–Drug Conjugate Production-Reference-Cited by-同舟云学术

AJICAP Second Generation: Improved Chemical Site-Specific Conjugation Technology for Antibody–Drug Conjugate Production

Published:2023-03-09 Issue: Volume: Page:
ISSN:1043-1802
Container-title:Bioconjugate Chemistry
language:en
Short-container-title:Bioconjugate Chem.

Author:

Fujii Tomohiro¹,Matsuda Yutaka²^ORCID,Seki Takuya¹,Shikida Natsuki¹,Iwai Yusuke¹,Ooba Yuri¹,Takahashi Kazutoshi¹,Isokawa Muneki¹,Kawaguchi Sayaka¹,Hatada Noriko¹,Watanabe Tomohiro¹,Takasugi Rika¹,Nakayama Akira¹,Shimbo Kazutaka¹,Mendelsohn Brian A.²^ORCID,Okuzumi Tatsuya¹,Yamada Kei¹

Affiliation:

1. Ajinomoto Co., Inc., 1-1, Suzuki-Cho, Kawasaki-Ku, Kawasaki-Shi, Kanagawa 210-8681, Japan

2. Ajinomoto Bio-Pharma Services, 11040 Roselle Street, San Diego, California 92121, United States

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Pharmaceutical Science,Pharmacology,Biomedical Engineering,Bioengineering,Biotechnology

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.bioconjchem.3c00040

Reference37 articles.

1. Site-selective modification strategies in antibody–drug conjugates

2. An overview of process development for antibody-drug conjugates produced by chemical conjugation technology

3. DS-8201a, A Novel HER2-Targeting ADC with a Novel DNA Topoisomerase I Inhibitor, Demonstrates a Promising Antitumor Efficacy with Differentiation from T-DM1

4. The Latest Research and Development into the Antibody–Drug Conjugate, [fam-] Trastuzumab Deruxtecan (DS-8201a), for HER2 Cancer Therapy

5. Recent Advances in Drug–Antibody Ratio Determination of Antibody–Drug Conjugates

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In vivo Antibody Painting for Next Generation Weight Loss Drugs;2024-08-23

2. Design and synthesis of novel site-specific antibody-drug conjugates that target TROP2;Bioorganic & Medicinal Chemistry;2024-08

3. Site-specific bioconjugation and nuclear imaging;Current Opinion in Chemical Biology;2024-08

4. Antibody–drug conjugates in cancer therapy: mechanisms and clinical studies;MedComm;2024-07-28

5. Recent Advances in Targeted Cancer Therapy: Are PDCs the Next Generation of ADCs?;Journal of Medicinal Chemistry;2024-07-09